Programs
Clinical Proteomic Tumor Analysis Consortium
The National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) is composed of three integrated components:
- Proteome Characterization Centers (PCCs)
- Data Coordinating Center
- Resource Center
These components are working in tandem to better understand cancer biology and the protein component of tumor tissue. A key CPTAC partnership is with The Cancer Genome Atlas, where most of the genomically characterized tumor samples originate from. This scientific partnership is providing a link to connect the genome to the proteome. Read more here for more information about CPTAC.
Small Business Innovation Research
NCI's Office of Cancer Clinical Proteomics Research (OCCPR) works with the Small Business Innovation Research Program to help small business to develop and commercialize novel proteomic technologies and products to prevent, diagnose, and treat cancer. To find out more information about previously funded small business click here.
Trans-NIH Programs
Highlights coordination and activities between the OCCPR and NIH Common Fund program areas.
Completed Programs
Also additional information regarding previously funded programs and initiatives from the Office of Cancer Clinical Proteomics Research are available:
Launch Antibody Portal »
The Antibody Portal serves as a public resource of monoclonal antibodies made available by the NCI for the scientific community to support protein/peptide measurement and analysis efforts.
Launch Data Portal »
The Clinical Proteomic Tumor Analysis Consortium (CPTAC) Data Portal provides a platform for researchers to search, download, and analyze data sets generated by CPTAC.